Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natco Pharma Limited

http://www.natcopharma.co.in

Latest From Natco Pharma Limited

Philippines FDA Slashes Approval Timelines For Generic Drugs

The Philippines Food and Drug Administration is set to shorten the timeline for generic review and approval from 120 days to just 45 days, as part of efforts to register new generics and bring down prices.

Regulation Policy

Torrent Evasive On Cipla Question, But Comfortable With Domestic Acquisitions

Torrent management avoided commenting on valuations or whether big-ticket acquisitions are on the cards during a call to discuss fiscal Q2 results, as it faced a volley of questions on the topic following media reports of its interest in acquiring Cipla. Meanwhile, the Brazil business posted handsome gains during the quarter, while the US business shrunk.

Sales & Earnings Strategy

Torrent Evasive On Cipla Question, But Comfortable With Domestic Acquisitions

Torrent management avoided commenting on valuations or whether big-ticket acquisitions are on the cards during a call to discuss fiscal Q2 results, as it faced a volley of questions on the topic following media reports of its interest in acquiring Cipla. Meanwhile, the Brazil business posted handsome gains during the quarter, while the US business shrunk

Commercial Business Strategies

Aurobindo Reverses Roles With Pfizer As It Drops Pin On Indonesia: What’s The Draw?

Aurobindo’s acquisition of 15 brands from Pfizer and Viatris to gain entry to Indonesia marks a role reversal of sorts as Pfizer has been licensing generics from Aurobindo. Scrip takes a look at some of the opportunities and challenges in this growing Southeast Asian market.

Deals Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
UsernamePublicRestriction

Register